07/22/22 |
NIH |
HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery |
Link |
NIH NOSI |
Application due: 06/25/25 |
01/17/24 |
NCI |
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention |
Link |
NIH NOSI |
Application due: 05/08/29 |
12/05/22 |
NIH |
Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics |
Link |
NIH NOSI |
Application due: 01/08/26 |
04/11/23 |
NIH |
Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities |
Link |
NIH NOSI |
Application due: 06/06/26 |
10/04/23 |
NCI |
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk |
Link |
NIH NOSI |
Application due: 09/08/24 |
04/10/23 |
NIH |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health |
Link |
NIH NOSI |
Application due: 05/09/24 |
12/20/23 |
NCI |
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications |
Link |
NIH NOSI |
Application due: 01/27/27 |
07/22/22 |
NIH |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
06/17/22 |
NIH |
Notice of Special Interest (NOSI): Developing Academic Research Enhancement Award (AREA) and Research Enhancement Award Program (REAP) for Institutions with an emphasis on Down syndrome research (R15 Clinical Trial Not Allowed) |
Link |
NIH NOSI |
Application due: 04/11/25 |
12/13/23 |
NCI |
Notice of Intent to Publish a Notice of Funding Opportunity for National Cancer Institute's Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (U54 Clinical Trial Optional) |
Link |
NIH NOSI |
Application due: 09/25/24 |
06/17/22 |
NIH |
Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NIH NOSI |
Application due: 06/02/25 |
03/24/23 |
NCI |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
03/11/24 |
NCI |
Notice of Special Interest (NOSI): Telehealth Research in Cancer Care |
Link |
NIH NOSI |
Application due: 03/17/26 |
03/14/23 |
NCI |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors |
Link |
NIH NOSI |
Application due: 10/09/24 |
03/11/24 |
NCI |
Notice of Special Interest (NOSI): Administrative supplements to understand effects of within-group heterogeneity on cancer control outcomes in underrepresented populations |
Link |
NIH NOSI |
Application due: 04/30/24 |
03/11/24 |
NCI |
Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities |
Link |
NIH NOSI |
Application due: 10/10/26 |
06/13/22 |
NIH |
Notice of Special Interest (NOSI): Climate Change and Health |
Link |
NIH NOSI |
Application due: 05/08/25 |
04/17/20 |
NIH |
Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 |
Link |
NIH COVID-19 |
|
04/17/20 |
NIH |
NIH Funding Opportunities Specific to COVID-19 (various) |
Link |
NIH COVID-19 |
See list of notices for funding opps and due dates |
03/20/20 |
NIH |
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
Link |
NIH |
|
05/22/20 |
NIH |
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/21/18 |
NIH |
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/27/19 |
NIH |
The NCI Transition Career Development Award (K22 Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
03/01/21 |
NIH |
Tobacco Regulatory Science (R01 Clinical Trial Optional) |
Link |
NIH |
|
12/11/20 |
NIH |
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
04/08/22 |
NCI |
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/17/19 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) |
Link |
NIH |
Standard due dates apply |
03/08/23 |
NCI |
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/17/24 |
08/04/22 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
05/06/19 |
NIH |
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) |
Link |
NIH |
Standard due dates apply |
08/29/23 |
NCI |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
03/11/24 |
NIH |
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) |
Link |
NIH |
Application due: 06/18/24 |
07/23/20 |
NIH |
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard dates |
05/22/20 |
NIH |
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
11/22/19 |
NIH |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
10/21/22 |
NCI |
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, 2023 (P50 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
11/30/18 |
NIH |
Examination of Survivorship Care Planning Efficacy and Impact (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
01/11/19 |
NIH |
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21) |
Link |
NIH |
Standard due dates apply |
10/14/22 |
NCI |
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/17/19 |
NIH |
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) |
Link |
NIH |
Standard due dates apply |
08/04/22 |
NIH |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
05/06/19 |
NIH |
Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21) |
Link |
NIH |
Standard due dates apply |
06/06/22 |
NIH |
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 09/11/24 |
03/11/24 |
NCI |
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Application due: 06/14/24 |
02/27/20 |
NIH |
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) |
Link |
NIH |
|
07/31/20 |
NIH |
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
05/22/20 |
NIH |
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
11/21/18 |
NIH |
Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
10/09/20 |
NIH |
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
Link |
NIH |
A successor-in-interest request must be made before the anticipated start date … |
11/30/18 |
NIH |
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/04/21 |
NIH |
Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease |
Link |
NIH |
Application due: 05/07/24 |
01/14/21 |
NIH |
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
10/14/22 |
NCI |
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
03/01/19 |
NIH |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) |
Link |
NIH |
Standard due dates apply |
05/06/19 |
NIH |
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/02/19 |
NIH |
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/27/20 |
NIH |
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
|
08/01/18 |
NIH |
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03) |
Link |
NIH |
Standard dates apply |
05/22/20 |
NIH |
NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Standard due dates apply |
11/21/18 |
NIH |
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/01/22 |
NIH |
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 05/03/24 |
11/30/18 |
NIH |
Methodology and Measurement in the Behavioral and Social Sciences (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
02/14/20 |
NIH |
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/17/19 |
NIH |
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) |
Link |
NIH |
Standard due dates apply |
01/21/22 |
NIH |
Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional) |
Link |
NIH |
Standard due dates apply |
05/06/19 |
NIH |
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/02/19 |
NIH |
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01) |
Link |
NIH |
Standard due dates apply |
02/27/20 |
NIH |
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required ) |
Link |
NIH |
|
08/01/18 |
NIH |
Secondary Analyses of Alcohol and Chronic Disease (R03) |
Link |
NIH |
Standard dates apply |
11/21/18 |
NIH |
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/13/20 |
NIH |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
11/30/18 |
NIH |
Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
09/11/20 |
NIH |
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/13/21 |
NIH |
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/17/19 |
NIH |
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
01/21/22 |
NIH |
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
05/06/19 |
NIH |
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |